Elsbernd Brian 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Nov 14, 2025
Insider Transaction Report
Form 4
Elsbernd Brian
Chief Compliance/Legal Officer
Transactions
- Sale
Common Stock, par value $0.001 per share
2025-11-12$22.70/sh+40,000$908,000→ 231,039 total
Footnotes (2)
- [F1]Shares were sold for personal reasons and not as a result of any disagreement with the Company.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in a range from $22.55 to $23.00 per share.